FDA Authorizes First At-Home Sample Collection Test for COVID-19
WASHINGTON – The Food and Drug Administration Tuesday approved the first diagnostic test for the coronavirus that allows people to collect their sample at home — a development that could greatly expand testing options in states fighting to corral the outbreak.
The COVID-19 RT-PCR from LabCorp will initially only be available to health care workers and first responders under a doctor’s orders.
The sample, collected via swab, will still have to be shipped for processing back to LabCorp, which operates diagnostic labs throughout the U.S.
Before gaining access to the home test, people are screened using an online questionnaire.
If authorized by a physician, LabCorp will ship a testing kit to their home.
The kit includes cotton swabs, a collection tube, an insulated pouch and box to ship the specimen back to LabCorp. To take a sample, a cotton swab is swirled in each nostril. The test results are posted online to a secure company website.
The company said it will make the test kit available in the coming weeks. Each will cost $119. The kits will not be available in Maryland, New Jersey, New York and Rhode Island. Those states have laws prohibiting testing with at-home kits.
FDA Commissioner Stephan Hawn said in a statement the agency authorized the self-swab test based on data showing it is “as safe and accurate as sample collection at a doctor’s office, hospital or other testing site.”
“Throughout this pandemic we have been facilitating test development to ensure patients access to accurate diagnostics, which includes supporting the development of reliable and accurate at-home sample collection options,” he said.
“The FDA’s around-the-clock work since this outbreak began has resulted in the authorization of more than 50 diagnostic tests and engagement with over 350 test developers,” he continued.
The FDA said it will continue to work with test developers to determine whether or not Q-tip-style cotton swabs can be used safely and effectively with other tests.
In The News
New federal guidelines that acknowledged the role of aerosols in the spread of COVID-19 were removed Monday from the website of the Centers for Disease Control and Prevention, which said they had been posted by mistake. The updated information about coronavirus-laden aerosols, which came to the... Read More
PHILADELPHIA — Dawn Pittman retired from teaching in 2013 after more than three decades. But Pittman has no plans to give up her passion — even in a pandemic. When Camden resumes in-person learning, possibly in January, she hopes to answer the call as a substitute.... Read More
WASHINGTON — Democratic presidential nominee Joe Biden on Sunday portrayed President Trump’s determination to lock in conservative control of the Supreme Court in the final weeks of the presidential campaign as a potent threat not only to Americans’ health care, but also to the nation’s democratic... Read More
WASHINGTON — President Donald Trump contradicted one of his administration’s top scientists and announced Wednesday that widespread distribution of a coronavirus vaccine would begin as early as next month, further rattling the scientific and public health communities and stoking rival Joe Biden’s claim that Trump can’t... Read More
WASHINGTON -- Congress discussed proposals Wednesday to switch the United States to 100% clean energy as Western governors confronting out-of-control wildfires demand action on global warming. A House Energy and Commerce subcommittee is trying to figure out a way to recover jobs lost during the coronavirus... Read More
NEW YORK, N.Y.- The City of New York on Monday implemented a new COVID "Response Team" to monitor the city's schools and hopefully prevent a resurgence of the coronavirus in one of the nation's hardest hit municipalities. The city's new COVID Response Situation Room is a... Read More